WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced that on the day after launch it had exceeded its Quell pre-order thirty day campaign goal. The Company reported preorders for over 500 Quell devices. Demand exceeded company projections and the initial offer sold out in

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced a pre-order campaign on the world's largest crowdfunding platform, Indiegogo. With the campaign that begins March 2 , consumers and healthcare professionals will have the ability to purchase Quell Wearable Pain Relief

Revenue Growth, Record Diabetes Product Revenue, New Product Unveiling WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO), today reported financial and business highlights for the quarter and year ended December 31, 2014 .

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2014 full year and fourth quarter financial results before the opening of the market on February 12, 2015 . The Company will host a conference call at 8:00 a.m., Eastern Time on February

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq:NURO) reported that its President and Chief Executive Officer, Shai N. Gozani , M.D., Ph.D., provided an update and overview of company business activities on January 14, 2015 at the Biotech Showcase 2015 conference in San Francisco . Dr.

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported strong interest in Quell coming out of last week's Consumer Electronics Show (CES). According to Frank McGillin , SVP and General Manager of Consumer Health at NeuroMetrix , "In the first several days that the

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported today that Quell has been featured in several forums during this year's International Consumer Electronics Show (CES). Among the highlights: NeuroMetrix President and Chief Executive Officer, Shai N.

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported today that industry insiders got their first look at Quell during day 1 of this year's International Consumer Electronics Show (CES). Quell utilizes NeuroMetrix's proprietary non-invasive neurostimulation technology to

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. announced today that Shai N. Gozani M.D ., Ph.D., President and Chief Executive Officer, will be presenting at the Biotech Showcase 2015 Conference being held in San Francisco, CA. Dr. Gozani intends to provide an overall business update and a

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) will unveil and demonstrate Quell, a novel wearable pain relief device at the 2015 International Consumer Electronics show (CES) January 6-9 in Las Vegas . Attendees will get their first glimpse of Quell at Booth # 73311 in the